XEROX CORP's ticker is XRXXXXX and the CUSIP is 984121103. A total of 553 filers reported holding XEROX CORP in Q1 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $510,230,000 | +1524.0% | 69,513,636 | +1831.5% | 0.03% | -36.4% |
Q4 2016 | $31,419,000 | -2.1% | 3,598,881 | +13.6% | 0.04% | -4.3% |
Q3 2016 | $32,092,000 | +4.2% | 3,168,007 | -2.4% | 0.05% | 0.0% |
Q2 2016 | $30,795,000 | -7.3% | 3,245,012 | +9.1% | 0.05% | -13.2% |
Q1 2016 | $33,203,000 | -12.8% | 2,975,212 | -17.0% | 0.05% | -5.4% |
Q4 2015 | $38,088,000 | +11.2% | 3,583,092 | +1.8% | 0.06% | +3.7% |
Q3 2015 | $34,253,000 | -5.2% | 3,520,454 | +3.7% | 0.05% | 0.0% |
Q2 2015 | $36,121,000 | -22.2% | 3,394,809 | -6.1% | 0.05% | -15.6% |
Q1 2015 | $46,446,000 | -5.5% | 3,614,582 | +1.9% | 0.06% | -8.6% |
Q4 2014 | $49,175,000 | +3.3% | 3,547,934 | -1.4% | 0.07% | 0.0% |
Q3 2014 | $47,603,000 | -10.7% | 3,598,029 | -16.0% | 0.07% | -11.4% |
Q2 2014 | $53,302,000 | +6.1% | 4,284,673 | -3.6% | 0.08% | -2.5% |
Q1 2014 | $50,236,000 | -13.5% | 4,445,621 | -6.8% | 0.08% | -14.7% |
Q4 2013 | $58,047,000 | +16.1% | 4,769,644 | -1.8% | 0.10% | +1.1% |
Q3 2013 | $49,992,000 | +120.2% | 4,858,420 | +94.1% | 0.09% | +108.9% |
Q2 2013 | $22,700,000 | – | 2,502,686 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Icahn Capital | 24,757,502 | $711,283,000 | 3.64% |
VALUEWORKS LLC | 133,982 | $3,849,000 | 2.88% |
Polaris Capital Management, LLC | 752,350 | $21,615,000 | 1.27% |
IHT Wealth Management, LLC | 52 | $1,051,000 | 0.51% |
Hanson & Doremus Investment Management | 46,861 | $1,346,000 | 0.50% |
Sonora Investment Management, LLC | 44,045 | $1,265,413,000 | 0.24% |
Boltwood Capital Management | 11,983 | $344,000 | 0.23% |
DREMAN VALUE MANAGEMENT, L L C | 59,013 | $756,000 | 0.21% |
Adirondack Research & Management Inc. | 16,883 | $485,000 | 0.19% |
Fruth Investment Management | 12,633 | $362,000 | 0.17% |